Antibodies as Drugs _ Immunological Scaffolds as Therapeutics

While monoclonal antibodies are now an established class of drugs in oncology and inflammation, exciting progress has been recently made on next generation, engineered therapeutic antibodies and alternative immunological scaffolds, with first examples from this class being recently approved by FDA and EMA. This symposium will review progress in this area including lessons learned in the clinic and how this can be applied to new targets and drug candidates.
+ show speakers and program
cancer, antibodies, immunology

8 Feb - 13 Feb 2015
meeting website